Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients

Andrew Dewolfe, Barbara Lopez, Lee M. Arcement, Kathy Hebert

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background The incidence of congestive heart failure (CHF) has not significantly declined over the past 50 years, and overall survival rates are low at 5 years following diagnosis. Numerous studies have shown low serum sodium to be a poor prognostic indicator of all cause mortality in CHF patients. Hypothesis The goal of this hypothesis was to validate if hyponatremia is an important predictor of mortality in an outpatient population of CHF patients on maximal combined angiotensin-converting enzyme inhibitor (ACEI) and β-blocker therapy. Methods A total of 364 (13% with hyponatremia) patients with CHF (ejection fraction [EF] â40%) were enrolled in a heart failure disease management program. The mean New York Heart Association (NYHA) class was II.XII. The average baseline serum sodium was 138.2 mEq/L. Results We evaluated the relationship between hyponatremia (<135 mEq/L) and all-cause mortality at 40 months. During follow-up, 8 patients in the hyponatremia group compared to 31 in the normonatremic group died. Results of Kaplan-Meier analyses indicated there were no significant differences in mortality between the hyponatremia and normonatremic groups (log-rank test = 0.39). Results for Cox proportional hazards models indicated low sodium was not a significant predictor of mortality (unadjusted odds ratio [OR]: 1.41, 95% confidence interval [CI]: 0.65, 3.07; adjusted OR: 1.60, 95% CI: 0.57, 4.53). Conclusions The relationship between hyponatremia and all-cause mortality did not reach significance. Hyponatremia did not significantly predict mortality in a CHF population on maximal medical therapy.

Original languageEnglish
JournalClinical Cardiology
Volume33
Issue number12
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Fingerprint

Hyponatremia
Heart Failure
Sodium
Mortality
Serum
Odds Ratio
Confidence Intervals
Kaplan-Meier Estimate
Disease Management
Proportional Hazards Models
Angiotensin-Converting Enzyme Inhibitors
Population
Heart Diseases
Outpatients
Survival Rate
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients. / Dewolfe, Andrew; Lopez, Barbara; Arcement, Lee M.; Hebert, Kathy.

In: Clinical Cardiology, Vol. 33, No. 12, 01.12.2010.

Research output: Contribution to journalArticle

Dewolfe, Andrew ; Lopez, Barbara ; Arcement, Lee M. ; Hebert, Kathy. / Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients. In: Clinical Cardiology. 2010 ; Vol. 33, No. 12.
@article{09f7b8a04a3a476f86fee74fcf39cbe3,
title = "Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients",
abstract = "Background The incidence of congestive heart failure (CHF) has not significantly declined over the past 50 years, and overall survival rates are low at 5 years following diagnosis. Numerous studies have shown low serum sodium to be a poor prognostic indicator of all cause mortality in CHF patients. Hypothesis The goal of this hypothesis was to validate if hyponatremia is an important predictor of mortality in an outpatient population of CHF patients on maximal combined angiotensin-converting enzyme inhibitor (ACEI) and β-blocker therapy. Methods A total of 364 (13{\%} with hyponatremia) patients with CHF (ejection fraction [EF] {\^a}40{\%}) were enrolled in a heart failure disease management program. The mean New York Heart Association (NYHA) class was II.XII. The average baseline serum sodium was 138.2 mEq/L. Results We evaluated the relationship between hyponatremia (<135 mEq/L) and all-cause mortality at 40 months. During follow-up, 8 patients in the hyponatremia group compared to 31 in the normonatremic group died. Results of Kaplan-Meier analyses indicated there were no significant differences in mortality between the hyponatremia and normonatremic groups (log-rank test = 0.39). Results for Cox proportional hazards models indicated low sodium was not a significant predictor of mortality (unadjusted odds ratio [OR]: 1.41, 95{\%} confidence interval [CI]: 0.65, 3.07; adjusted OR: 1.60, 95{\%} CI: 0.57, 4.53). Conclusions The relationship between hyponatremia and all-cause mortality did not reach significance. Hyponatremia did not significantly predict mortality in a CHF population on maximal medical therapy.",
author = "Andrew Dewolfe and Barbara Lopez and Arcement, {Lee M.} and Kathy Hebert",
year = "2010",
month = "12",
day = "1",
doi = "10.1002/clc.20560",
language = "English",
volume = "33",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients

AU - Dewolfe, Andrew

AU - Lopez, Barbara

AU - Arcement, Lee M.

AU - Hebert, Kathy

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Background The incidence of congestive heart failure (CHF) has not significantly declined over the past 50 years, and overall survival rates are low at 5 years following diagnosis. Numerous studies have shown low serum sodium to be a poor prognostic indicator of all cause mortality in CHF patients. Hypothesis The goal of this hypothesis was to validate if hyponatremia is an important predictor of mortality in an outpatient population of CHF patients on maximal combined angiotensin-converting enzyme inhibitor (ACEI) and β-blocker therapy. Methods A total of 364 (13% with hyponatremia) patients with CHF (ejection fraction [EF] â40%) were enrolled in a heart failure disease management program. The mean New York Heart Association (NYHA) class was II.XII. The average baseline serum sodium was 138.2 mEq/L. Results We evaluated the relationship between hyponatremia (<135 mEq/L) and all-cause mortality at 40 months. During follow-up, 8 patients in the hyponatremia group compared to 31 in the normonatremic group died. Results of Kaplan-Meier analyses indicated there were no significant differences in mortality between the hyponatremia and normonatremic groups (log-rank test = 0.39). Results for Cox proportional hazards models indicated low sodium was not a significant predictor of mortality (unadjusted odds ratio [OR]: 1.41, 95% confidence interval [CI]: 0.65, 3.07; adjusted OR: 1.60, 95% CI: 0.57, 4.53). Conclusions The relationship between hyponatremia and all-cause mortality did not reach significance. Hyponatremia did not significantly predict mortality in a CHF population on maximal medical therapy.

AB - Background The incidence of congestive heart failure (CHF) has not significantly declined over the past 50 years, and overall survival rates are low at 5 years following diagnosis. Numerous studies have shown low serum sodium to be a poor prognostic indicator of all cause mortality in CHF patients. Hypothesis The goal of this hypothesis was to validate if hyponatremia is an important predictor of mortality in an outpatient population of CHF patients on maximal combined angiotensin-converting enzyme inhibitor (ACEI) and β-blocker therapy. Methods A total of 364 (13% with hyponatremia) patients with CHF (ejection fraction [EF] â40%) were enrolled in a heart failure disease management program. The mean New York Heart Association (NYHA) class was II.XII. The average baseline serum sodium was 138.2 mEq/L. Results We evaluated the relationship between hyponatremia (<135 mEq/L) and all-cause mortality at 40 months. During follow-up, 8 patients in the hyponatremia group compared to 31 in the normonatremic group died. Results of Kaplan-Meier analyses indicated there were no significant differences in mortality between the hyponatremia and normonatremic groups (log-rank test = 0.39). Results for Cox proportional hazards models indicated low sodium was not a significant predictor of mortality (unadjusted odds ratio [OR]: 1.41, 95% confidence interval [CI]: 0.65, 3.07; adjusted OR: 1.60, 95% CI: 0.57, 4.53). Conclusions The relationship between hyponatremia and all-cause mortality did not reach significance. Hyponatremia did not significantly predict mortality in a CHF population on maximal medical therapy.

UR - http://www.scopus.com/inward/record.url?scp=78650665656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650665656&partnerID=8YFLogxK

U2 - 10.1002/clc.20560

DO - 10.1002/clc.20560

M3 - Article

C2 - 21184540

AN - SCOPUS:78650665656

VL - 33

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 12

ER -